Raab Michael
- SEC CIK
- 0001321402
In the past year, 10 open-market sale filings worth $2.57M and no purchases.
Current role at each company
- ARDX Ardelyx, Inc.President & CEOas of Aug 25, 2026
- FOLD Amicus Therapeutics, Inc.Directoras of Apr 27, 2026
- TPST Tempest Therapeutics, Inc.Directoras of Jan 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.57M
- 10 filings
- Net
- −$2.57M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Raab Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARDX Ardelyx, Inc.
President & CEO52 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 (view filing) | Aug 20 | 4 days | Raab MichaelPresident & CEO | SSale | −2.57K | $1.32 | −$3.40K | −0.8%329.7K after | |
| Nov 24, 2021 (view filing) | Nov 22 | 2 days | Raab MichaelPresident & CEO | SSale | −2.61K | $0.99 | −$2.58K | −0.4%631.8K after | |
| Feb 25, 2022 (view filing) | Feb 22 | 3 daysLate | Raab MichaelPresident & CEO | SSale | −6.23K | $0.67 | −$4.17K | −0.8%775.6K after | |
| May 23, 2022 (view filing) | May 20 | 3 days | Raab MichaelPresident & CEO | SSale | −6.12K | $0.67 | −$4.10K | −0.8%772.5K after | |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Raab MichaelPresident & CEO | SSale | −103.6K | $0.6498 | −$67.3K | −13.4%668.8K after | 2 lots |
| Aug 24, 2022 (view filing) | Aug 22 | 2 days | Raab MichaelPresident & CEO | SSale | −6.15K | $0.98 | −$6.02K | −0.9%662.7K after | 3 lots |
| Sep 1, 2022 (view filing) | Aug 31 | 1 day | Raab MichaelPresident & CEO | PPurchase | +3.00K | $0.62 | +$1.86K | +0.5%665.7K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Raab MichaelPresident & CEO | SSale | −6.22K | $1.95 | −$12.1K | −0.9%659.5K after | 3 lots |
| Feb 24, 2023 (view filing) | Feb 21 | 3 daysLate | Raab MichaelPresident & CEO | SSale | −13.4K | $3.00 | −$40.3K | −1.5%896.0K after | |
| May 25, 2023 (view filing) | May 23 | 2 days | Raab MichaelPresident & CEO | SSale | −11.4K | $3.65 | −$41.5K | −1.3%887.7K after |
FOLD Amicus Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2022 (view filing) | May 2 | 2 days | Raab MichaelDirector | SSale | −15.0K | $6.99 | −$104.8K | −29.0%36.7K after | |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Raab MichaelDirector | SSale | −4.41K | $11.33 | −$49.9K | −6.8%60.0K after |